• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

靶向癌症中的信号转导和转录激活因子3(STAT3)及信号转导和转录激活因子5(STAT5)

Targeting STAT3 and STAT5 in Cancer.

作者信息

de Araujo Elvin D, Keserű György M, Gunning Patrick T, Moriggl Richard

机构信息

Centre for Medicinal Chemistry, University of Toronto at Mississauga, Mississauga, ON L5L 1C6, Canada.

Department of Chemical and Physical Sciences, University of Toronto at Mississauga, Mississauga, ON L5L 1C6, Canada.

出版信息

Cancers (Basel). 2020 Jul 22;12(8):2002. doi: 10.3390/cancers12082002.

DOI:10.3390/cancers12082002
PMID:32707820
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7465272/
Abstract

Insights into the mutational landscape of the human cancer genome coding regions defined about 140 distinct cancer driver genes in 2013, which approximately doubled to 300 in 2018 following advances in systems cancer biology studies [...].

摘要

2013年,对人类癌症基因组编码区突变图谱的深入研究确定了约140个不同的癌症驱动基因,随着系统癌症生物学研究的进展,到2018年这一数字大约翻了一番,达到300个[……]

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/58bb/7465272/4283a934defa/cancers-12-02002-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/58bb/7465272/4283a934defa/cancers-12-02002-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/58bb/7465272/4283a934defa/cancers-12-02002-g001.jpg

相似文献

1
Targeting STAT3 and STAT5 in Cancer.靶向癌症中的信号转导和转录激活因子3(STAT3)及信号转导和转录激活因子5(STAT5)
Cancers (Basel). 2020 Jul 22;12(8):2002. doi: 10.3390/cancers12082002.
2
Activation of STAT3 and STAT5 Signaling in Epithelial Ovarian Cancer Progression: Mechanism and Therapeutic Opportunity.STAT3和STAT5信号通路激活在上皮性卵巢癌进展中的作用:机制与治疗机遇
Cancers (Basel). 2019 Dec 19;12(1):24. doi: 10.3390/cancers12010024.
3
Pharmacological Inhibition of Oncogenic STAT3 and STAT5 Signaling in Hematopoietic Cancers.造血系统癌症中致癌性 STAT3 和 STAT5 信号通路的药理学抑制作用
Cancers (Basel). 2020 Jan 18;12(1):240. doi: 10.3390/cancers12010240.
4
Identification of coding and non-coding mutational hotspots in cancer genomes.癌症基因组中编码和非编码突变热点的鉴定。
BMC Genomics. 2017 Jan 5;18(1):17. doi: 10.1186/s12864-016-3420-9.
5
STAT3 and STAT5 Targeting for Simultaneous Management of Melanoma and Autoimmune Diseases.靶向 STAT3 和 STAT5 同时治疗黑色素瘤和自身免疫性疾病
Cancers (Basel). 2019 Sep 27;11(10):1448. doi: 10.3390/cancers11101448.
6
Implications of STAT3 and STAT5 signaling on gene regulation and chromatin remodeling in hematopoietic cancer.STAT3 和 STAT5 信号对造血系统癌症中基因调控和染色质重塑的影响。
Leukemia. 2018 Aug;32(8):1713-1726. doi: 10.1038/s41375-018-0117-x. Epub 2018 Mar 27.
7
Distinct roles of STAT3 and STAT5 in the pathogenesis and targeted therapy of breast cancer.STAT3 和 STAT5 在乳腺癌发病机制和靶向治疗中的不同作用。
Mol Cell Endocrinol. 2014 Jan 25;382(1):616-621. doi: 10.1016/j.mce.2013.03.010. Epub 2013 Mar 24.
8
STAT5 outcompetes STAT3 to regulate the expression of the oncogenic transcriptional modulator BCL6.STAT5 竞争胜过 STAT3 来调节致癌转录调节剂 BCL6 的表达。
Mol Cell Biol. 2013 Aug;33(15):2879-90. doi: 10.1128/MCB.01620-12. Epub 2013 May 28.
9
Chronic Inhibition of STAT3/STAT5 in Treatment-Resistant Human Breast Cancer Cell Subtypes: Convergence on the ROS/SUMO Pathway and Its Effects on xCT Expression and System xc- Activity.慢性抑制 STAT3/STAT5 对难治性人乳腺癌细胞亚型的作用:聚焦于 ROS/SUMO 途径及其对 xCT 表达和系统 xc- 活性的影响
PLoS One. 2016 Aug 11;11(8):e0161202. doi: 10.1371/journal.pone.0161202. eCollection 2016.
10
Long non-coding RNA RP11-468E2.5 curtails colorectal cancer cell proliferation and stimulates apoptosis via the JAK/STAT signaling pathway by targeting STAT5 and STAT6.长非编码 RNA RP11-468E2.5 通过靶向 STAT5 和 STAT6 抑制 JAK/STAT 信号通路从而抑制结直肠癌细胞增殖并促进其凋亡。
J Exp Clin Cancer Res. 2019 Nov 12;38(1):465. doi: 10.1186/s13046-019-1428-0.

引用本文的文献

1
Targeting c-Met in breast cancer: From mechanisms of chemoresistance to novel therapeutic strategies.靶向乳腺癌中的c-Met:从化疗耐药机制到新型治疗策略
Curr Res Pharmacol Drug Discov. 2024 Oct 22;7:100204. doi: 10.1016/j.crphar.2024.100204. eCollection 2024.
2
Role of microRNAs in triple‑negative breast cancer and new therapeutic concepts (Review).微小RNA在三阴性乳腺癌中的作用及新治疗理念(综述)
Oncol Lett. 2024 Jul 11;28(3):431. doi: 10.3892/ol.2024.14565. eCollection 2024 Sep.
3
Dynamic Changes in miRNA Expression during the Generation of Expanded and Activated NK Cells.

本文引用的文献

1
Tocilizumab in patients with severe COVID-19: a retrospective cohort study.托珠单抗治疗重症新型冠状病毒肺炎患者:一项回顾性队列研究
Lancet Rheumatol. 2020 Aug;2(8):e474-e484. doi: 10.1016/S2665-9913(20)30173-9. Epub 2020 Jun 24.
2
Case Fatality Rate of Cancer Patients with COVID-19 in a New York Hospital System.纽约医院系统中 COVID-19 癌症患者的病死率。
Cancer Discov. 2020 Jul;10(7):935-941. doi: 10.1158/2159-8290.CD-20-0516. Epub 2020 May 1.
3
Trying for a BRAF Slam Dunk. 尝试 BRAF 灌篮。
miRNA 在扩增和激活 NK 细胞过程中的表达动态变化。
Int J Mol Sci. 2023 Aug 31;24(17):13556. doi: 10.3390/ijms241713556.
4
The Multifaceted Role of STAT3 in NK-Cell Tumor Surveillance.STAT3 在 NK 细胞肿瘤监视中的多效作用。
Front Immunol. 2022 Jul 5;13:947568. doi: 10.3389/fimmu.2022.947568. eCollection 2022.
5
STAT1 and STAT3 Exhibit a Crosstalk and Are Associated with Increased Inflammation in Hepatocellular Carcinoma.信号转导和转录激活因子1(STAT1)与信号转导和转录激活因子3(STAT3)存在相互作用,且与肝细胞癌中炎症增加相关。
Cancers (Basel). 2022 Feb 23;14(5):1154. doi: 10.3390/cancers14051154.
6
JAK-STAT core cancer pathway: An integrative cancer interactome analysis.JAK-STAT 核心癌症通路:综合癌症互作组分析。
J Cell Mol Med. 2022 Apr;26(7):2049-2062. doi: 10.1111/jcmm.17228. Epub 2022 Mar 1.
7
Proteomimetics of Natural Regulators of JAK-STAT Pathway: Novel Therapeutic Perspectives.JAK-STAT 信号通路天然调节剂的蛋白质模拟物:新的治疗前景
Front Mol Biosci. 2022 Jan 3;8:792546. doi: 10.3389/fmolb.2021.792546. eCollection 2021.
8
Murine Oncostatin M Has Opposing Effects on the Proliferation of OP9 Bone Marrow Stromal Cells and NIH/3T3 Fibroblasts Signaling through the OSMR.鼠源骨桥蛋白对 OP9 骨髓基质细胞和 NIH/3T3 成纤维细胞增殖的影响及其通过 OSMR 信号转导的机制。
Int J Mol Sci. 2021 Oct 28;22(21):11649. doi: 10.3390/ijms222111649.
9
Targeting the JAK2/STAT3 Pathway-Can We Compare It to the Two Faces of the God Janus?靶向 JAK2/STAT3 通路——我们可以将其比作两面神雅努斯吗?
Int J Mol Sci. 2020 Nov 4;21(21):8261. doi: 10.3390/ijms21218261.
Cancer Discov. 2020 May;10(5):640-642. doi: 10.1158/2159-8290.CD-20-0231.
4
STAT5 is Expressed in CD34/CD38 Stem Cells and Serves as a Potential Molecular Target in Ph-Negative Myeloproliferative Neoplasms.信号转导和转录激活因子5(STAT5)在CD34/CD38干细胞中表达,并作为阴性骨髓增殖性肿瘤的潜在分子靶点。
Cancers (Basel). 2020 Apr 21;12(4):1021. doi: 10.3390/cancers12041021.
5
COVID-19 More Frequent, Severe in Cancer Patients.COVID-19 在癌症患者中更常见且更严重。
Cancer Discov. 2020 Jun;10(6):OF1. doi: 10.1158/2159-8290.CD-NB2020-032. Epub 2020 Apr 20.
6
Advances in covalent kinase inhibitors.共价激酶抑制剂的研究进展。
Chem Soc Rev. 2020 May 7;49(9):2617-2687. doi: 10.1039/c9cs00720b. Epub 2020 Mar 30.
7
Mutation Is Associated with STAT3 Activation in CD30 ALK ALCL.在CD30 ALK ALCL中,突变与STAT3激活相关。
Cancers (Basel). 2020 Mar 16;12(3):702. doi: 10.3390/cancers12030702.
8
mTOR and STAT3 Pathway Hyper-Activation is Associated with Elevated Interleukin-6 Levels in Patients with Shwachman-Diamond Syndrome: Further Evidence of Lymphoid Lineage Impairment.mTOR和STAT3信号通路的过度激活与施-戴二氏综合征患者白细胞介素-6水平升高相关:淋巴系损伤的进一步证据
Cancers (Basel). 2020 Mar 5;12(3):597. doi: 10.3390/cancers12030597.
9
Pharmacological Inhibition of Oncogenic STAT3 and STAT5 Signaling in Hematopoietic Cancers.造血系统癌症中致癌性 STAT3 和 STAT5 信号通路的药理学抑制作用
Cancers (Basel). 2020 Jan 18;12(1):240. doi: 10.3390/cancers12010240.
10
Activation of STAT3 and STAT5 Signaling in Epithelial Ovarian Cancer Progression: Mechanism and Therapeutic Opportunity.STAT3和STAT5信号通路激活在上皮性卵巢癌进展中的作用:机制与治疗机遇
Cancers (Basel). 2019 Dec 19;12(1):24. doi: 10.3390/cancers12010024.